§ 862.1117. B-type natriuretic peptide test system.
76 words·~1 min read·
/us/cfr/t21/s§ 862.1117·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. The B-type natriuretic peptide
(BNP)test system is an in vitro diagnostic device intended to measure BNP in whole blood and plasma. Measurements of BNP are used as an aid in the diagnosis of patients with congestive heart failure.
(b)Classification. Class II (special controls). The special control is “Class II Special Control Guidance Document for B-Type Natriuretic Peptide Premarket Notifications; Final Guidance for Industry and FDA Reviewers.” [66 FR 12734, Feb. 28, 2001]